Terumo BCTbio clinical trials
A subsidiary of Terumo Corporation
The registry lists 8 studies whose lead sponsor is Terumo BCTbio. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 14, 2024.
Registry sponsor names on this page
- Terumo BCTbio8 studies
Something wrong with this grouping? Tell us on the Terumo Corporation page.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. All Terumo Corporation studies →
- Efficacy and Safety of RBCs Derived From Mirasol-treated Whole Blood in Patients Requiring Chronic Transfusion (PRAISE)TerminatedNCT03329404Not applicable
Sponsor listed in the registry: Terumo BCTbio
- Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative ThrombocytopeniaTerminatedNCT02964325Not applicable
Sponsor listed in the registry: Terumo BCTbio
- Feasibility Study of Mirasol-Treated Whole Blood Red Cell Recovery and SurvivalTerminatedNCT00742001Phase 1
Sponsor listed in the registry: Terumo BCTbio
- Survival and Recovery of Radio-labeled Platelets Derived From Mirasol-treated Whole BloodCompletedNCT02330081Not applicable
Sponsor listed in the registry: Terumo BCTbio
- Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted MalariaCompletedNCT02118428Not applicable
Sponsor listed in the registry: Terumo BCTbio
- Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study)TerminatedNCT01368211Phase 2/3
Sponsor listed in the registry: Terumo BCTbio
- Inactivation of Whole Blood With MirasolCompletedNCT01907906Phase 1
Sponsor listed in the registry: Terumo BCTbio
- Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion ProductsCompletedNCT00263809Early Phase 1
Sponsor listed in the registry: Terumo BCTbio